Back to top

VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition 

Austin, Texas, United States, July 7th, 2026, FinanceWire Novartis has agreed to acquire Myricx Bio for $1.1 billion upfro...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: